Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, joined Flagship Pioneering Founder and CEO Noubar Afeyan in our Flagship Studio for a FutureCast conversation on what’s unique about leading a platform company, balancing breadth versus depth when it comes to pipeline development, and how a commitment to the science and a shared vision fuels innovation. More from Flagship @ JPM2025 here.
More from:
Human Health